AU2016245347B2 - Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same - Google Patents
Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same Download PDFInfo
- Publication number
- AU2016245347B2 AU2016245347B2 AU2016245347A AU2016245347A AU2016245347B2 AU 2016245347 B2 AU2016245347 B2 AU 2016245347B2 AU 2016245347 A AU2016245347 A AU 2016245347A AU 2016245347 A AU2016245347 A AU 2016245347A AU 2016245347 B2 AU2016245347 B2 AU 2016245347B2
- Authority
- AU
- Australia
- Prior art keywords
- cells
- gfp
- ptd4
- polypeptide
- cys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562145760P | 2015-04-10 | 2015-04-10 | |
| US62/145,760 | 2015-04-10 | ||
| US201562246892P | 2015-10-27 | 2015-10-27 | |
| US62/246,892 | 2015-10-27 | ||
| PCT/CA2016/050403 WO2016161516A1 (en) | 2015-04-10 | 2016-04-08 | Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2016245347A1 AU2016245347A1 (en) | 2017-11-09 |
| AU2016245347B2 true AU2016245347B2 (en) | 2021-01-28 |
Family
ID=57071637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016245347A Active AU2016245347B2 (en) | 2015-04-10 | 2016-04-08 | Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9738687B2 (enExample) |
| EP (1) | EP3280739B1 (enExample) |
| JP (2) | JP6956705B2 (enExample) |
| KR (2) | KR102697262B1 (enExample) |
| CN (1) | CN107636017B (enExample) |
| AU (1) | AU2016245347B2 (enExample) |
| CA (2) | CA2981716C (enExample) |
| ES (1) | ES2864758T3 (enExample) |
| IL (1) | IL254919B (enExample) |
| SG (1) | SG11201708336YA (enExample) |
| WO (1) | WO2016161516A1 (enExample) |
Families Citing this family (102)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6956705B2 (ja) * | 2015-04-10 | 2021-11-02 | フェルダン・バイオ・インコーポレーテッド | 標的真核細胞のサイトゾルへのポリペプチドカーゴの形質導入効率を改善するためのポリペプチドベースのシャトル剤、その使用、それと関連する方法及びキット |
| US11293029B2 (en) | 2015-12-07 | 2022-04-05 | Zymergen Inc. | Promoters from Corynebacterium glutamicum |
| US9988624B2 (en) | 2015-12-07 | 2018-06-05 | Zymergen Inc. | Microbial strain improvement by a HTP genomic engineering platform |
| US11208649B2 (en) | 2015-12-07 | 2021-12-28 | Zymergen Inc. | HTP genomic engineering platform |
| WO2017175072A1 (en) * | 2016-04-08 | 2017-10-12 | Feldan Bio Inc. | Peptide shuttle based gene disruption |
| WO2017180587A2 (en) | 2016-04-11 | 2017-10-19 | Obsidian Therapeutics, Inc. | Regulated biocircuit systems |
| CA3025828A1 (en) | 2016-06-01 | 2017-12-07 | Kws Saat Se | Hybrid nucleic acid sequences for genome engineering |
| WO2018005655A2 (en) | 2016-06-30 | 2018-01-04 | Zymergen Inc. | Methods for generating a bacterial hemoglobin library and uses thereof |
| EP3478845A4 (en) | 2016-06-30 | 2019-07-31 | Zymergen, Inc. | METHOD OF GENERATING A GLUCOSE PERMEASE LIBRARY AND USES THEREOF |
| US20200283743A1 (en) | 2016-08-17 | 2020-09-10 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
| EP3500671B1 (en) | 2016-08-17 | 2024-07-10 | The Broad Institute, Inc. | Method of selecting target sequences for the design of guide rnas |
| AU2017341736B2 (en) * | 2016-10-12 | 2022-09-08 | Feldan Bio Inc. | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same |
| US11629170B2 (en) | 2016-10-12 | 2023-04-18 | Feldan Bio Inc. | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same |
| US9982267B2 (en) | 2016-10-12 | 2018-05-29 | Feldan Bio Inc. | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same |
| US11519009B2 (en) | 2017-01-09 | 2022-12-06 | University Of Massachusetts | Complexes for gene deletion and editing |
| WO2018183908A1 (en) | 2017-03-31 | 2018-10-04 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating ovarian tumors |
| WO2018183850A2 (en) * | 2017-03-31 | 2018-10-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods, systems, and compositions for inhibiting virulance of a/e family pathogens |
| EP3610266A4 (en) | 2017-04-12 | 2021-04-21 | Massachusetts Eye and Ear Infirmary | TUMOR SIGNATURE FOR METASTASIS, COMPOSITIONS OF MATERIAL AND THEIR METHODS OF USE |
| WO2018209324A2 (en) | 2017-05-11 | 2018-11-15 | The Broad Institute, Inc. | Methods and compositions of use of cd8+ tumor infiltrating lymphocyte subtypes and gene signatures thereof |
| US12297436B2 (en) | 2017-05-18 | 2025-05-13 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
| EP3635112A2 (en) | 2017-06-06 | 2020-04-15 | Zymergen, Inc. | A htp genomic engineering platform for improving fungal strains |
| EP3485013B1 (en) | 2017-06-06 | 2021-03-24 | Zymergen, Inc. | A htp genomic engineering platform for improving escherichia coli |
| WO2018232195A1 (en) | 2017-06-14 | 2018-12-20 | The Broad Institute, Inc. | Compositions and methods targeting complement component 3 for inhibiting tumor growth |
| EP3645054A4 (en) | 2017-06-26 | 2021-03-31 | The Broad Institute, Inc. | CRISPR / CAS-ADENINE DESAMINASE COMPOSITIONS, TARGETED NUCLEIC ACID EDITING SYSTEMS AND METHODS |
| US12049643B2 (en) | 2017-07-14 | 2024-07-30 | The Broad Institute, Inc. | Methods and compositions for modulating cytotoxic lymphocyte activity |
| WO2019018440A1 (en) | 2017-07-17 | 2019-01-24 | The Broad Institute, Inc. | HUMAN COLON CELL ATLAS IN GOOD HEALTH AND WITH HEMORRHAGIC RECTO-COLITIS |
| IL271283B2 (en) | 2017-08-04 | 2024-04-01 | Syngenta Participations Ag | Methods and compositions for targeted genomic insertion |
| KR102338449B1 (ko) | 2017-09-21 | 2021-12-10 | 더 브로드 인스티튜트, 인코퍼레이티드 | 표적화된 핵산 편집을 위한 시스템, 방법, 및 조성물 |
| US20200255828A1 (en) | 2017-10-04 | 2020-08-13 | The Broad Institute, Inc. | Methods and compositions for altering function and structure of chromatin loops and/or domains |
| EP3710039A4 (en) | 2017-11-13 | 2021-08-04 | The Broad Institute, Inc. | METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER BY TARGETING THE CLEC2D-KLRB1 PATH |
| US12171783B2 (en) | 2017-11-13 | 2024-12-24 | The Broad Institute, Inc. | Methods and compositions for targeting developmental and oncogenic programs in H3K27M gliomas |
| US12221720B2 (en) | 2017-11-13 | 2025-02-11 | The Broad Institute, Inc. | Methods for determining spatial and temporal gene expression dynamics during adult neurogenesis in single cells |
| US11332736B2 (en) | 2017-12-07 | 2022-05-17 | The Broad Institute, Inc. | Methods and compositions for multiplexing single cell and single nuclei sequencing |
| CA3084572A1 (en) | 2017-12-18 | 2019-06-27 | Syngenta Participations Ag | Targeted insertion sites in the maize genome |
| US20230193242A1 (en) | 2017-12-22 | 2023-06-22 | The Broad Institute, Inc. | Cas12b systems, methods, and compositions for targeted dna base editing |
| US11957695B2 (en) | 2018-04-26 | 2024-04-16 | The Broad Institute, Inc. | Methods and compositions targeting glucocorticoid signaling for modulating immune responses |
| US12281301B2 (en) | 2018-04-27 | 2025-04-22 | The Broad Institute, Inc. | Sequencing-based proteomics |
| US20210386829A1 (en) | 2018-05-04 | 2021-12-16 | The Broad Institute, Inc. | Compositions and methods for modulating cgrp signaling to regulate innate lymphoid cell inflammatory responses |
| US12060388B2 (en) | 2018-05-25 | 2024-08-13 | Yale University | Cell-penetrating peptides and methods of use thereof |
| WO2019232542A2 (en) | 2018-06-01 | 2019-12-05 | Massachusetts Institute Of Technology | Methods and compositions for detecting and modulating microenvironment gene signatures from the csf of metastasis patients |
| EP3806888B1 (en) | 2018-06-12 | 2024-01-31 | Obsidian Therapeutics, Inc. | Pde5 derived regulatory constructs and methods of use in immunotherapy |
| US12036240B2 (en) | 2018-06-14 | 2024-07-16 | The Broad Institute, Inc. | Compositions and methods targeting complement component 3 for inhibiting tumor growth |
| EP3833761A1 (en) | 2018-08-07 | 2021-06-16 | The Broad Institute, Inc. | Novel cas12b enzymes and systems |
| WO2020041380A1 (en) | 2018-08-20 | 2020-02-27 | The Broad Institute, Inc. | Methods and compositions for optochemical control of crispr-cas9 |
| JP7344300B2 (ja) | 2018-09-18 | 2023-09-13 | ブイエヌブイ ニューコ インク． | Ａｒｃベースのカプシドおよびその使用 |
| CN109232719B (zh) * | 2018-09-21 | 2021-06-29 | 中国科学院理化技术研究所 | 一种pH响应的抗菌肽及其制备方法和应用 |
| US20220411783A1 (en) | 2018-10-12 | 2022-12-29 | The Broad Institute, Inc. | Method for extracting nuclei or whole cells from formalin-fixed paraffin-embedded tissues |
| WO2020081730A2 (en) | 2018-10-16 | 2020-04-23 | Massachusetts Institute Of Technology | Methods and compositions for modulating microenvironment |
| US20210386788A1 (en) | 2018-10-24 | 2021-12-16 | Obsidian Therapeutics, Inc. | Er tunable protein regulation |
| KR20210088615A (ko) | 2018-10-31 | 2021-07-14 | 지머젠 인코포레이티드 | Dna 라이브러리의 다중 결정적 어셈블리 |
| US12402610B2 (en) | 2018-11-09 | 2025-09-02 | The Broad Institute, Inc. | Methods and compositions for modulating innate lymphoid cell pathogenic effectors |
| US12165743B2 (en) | 2018-11-09 | 2024-12-10 | The Broad Institute, Inc. | Compressed sensing for screening and tissue imaging |
| WO2020123716A1 (en) | 2018-12-11 | 2020-06-18 | Obsidian Therapeutics, Inc. | Membrane bound il12 compositions and methods for tunable regulation |
| CN113544266A (zh) | 2018-12-17 | 2021-10-22 | 博德研究所 | Crispr相关转座酶系统和其使用方法 |
| US12264323B2 (en) | 2018-12-17 | 2025-04-01 | The Broad Institute, Inc. | CRISPR CPF1 direct repeat variants |
| KR102351041B1 (ko) * | 2018-12-19 | 2022-01-13 | 한국화학연구원 | 인간 lrrc24 단백질 유래 세포막 투과 도메인 |
| WO2020130547A1 (ko) * | 2018-12-19 | 2020-06-25 | 한국화학연구원 | 인간 엘알알씨24 단백질 유래 세포막 투과 도메인 |
| US11739156B2 (en) | 2019-01-06 | 2023-08-29 | The Broad Institute, Inc. Massachusetts Institute of Technology | Methods and compositions for overcoming immunosuppression |
| US12115212B2 (en) * | 2019-01-18 | 2024-10-15 | L & J Bio Co., Ltd. | Methods of decreasing amyloid beta (Aβ) plaque deposition and hyperphosphorylated tau plaque deposition in Alzheimer's disease using a cystatin C fusion protein |
| CN111471665B (zh) * | 2019-01-23 | 2023-07-04 | 上海科技大学 | 一种dna环化分子及其用途 |
| CN109734781B (zh) * | 2019-01-31 | 2021-12-14 | 东北农业大学 | 一种抗热带念珠菌肽及其制备方法和应用 |
| US12215382B2 (en) | 2019-03-01 | 2025-02-04 | The General Hospital Corporation | Liver protective MARC variants and uses thereof |
| JP7545985B2 (ja) | 2019-03-01 | 2024-09-05 | シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト | 天然ｍｉＲＮＡのゲノム編集による標的遺伝子発現の抑制 |
| SG11202109225WA (en) | 2019-03-08 | 2021-09-29 | Obsidian Therapeutics Inc | Cd40l compositions and methods for tunable regulation |
| KR20210136997A (ko) | 2019-03-08 | 2021-11-17 | 지머젠 인코포레이티드 | 미생물에서 반복적 게놈 편집 |
| US11053515B2 (en) | 2019-03-08 | 2021-07-06 | Zymergen Inc. | Pooled genome editing in microbes |
| CN113966397A (zh) | 2019-03-08 | 2022-01-21 | 黑曜石疗法公司 | 人碳酸酐酶2组合物和用于可调调节的方法 |
| WO2020186237A1 (en) | 2019-03-13 | 2020-09-17 | The Broad Institute, Inc. | Microglial progenitors for regeneration of functional microglia in the central nervous system and therapeutics uses thereof |
| WO2020191102A1 (en) | 2019-03-18 | 2020-09-24 | The Broad Institute, Inc. | Type vii crispr proteins and systems |
| RU2707542C1 (ru) | 2019-03-28 | 2019-11-27 | Федеральное бюджетное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ЦНИИ Эпидемиологии Роспотребнадзора) | Способ получения препарата рекомбинантной нуклеазы CAS, по существу, свободного от бактериальных эндотоксинов, полученный данным способом препарат и содержащий его набор для использования в системе CRISPR/Cas |
| CA3040645A1 (en) * | 2019-04-18 | 2020-10-18 | Feldan Bio Inc. | Peptide-based non-proteinaceous cargo delivery |
| US20220249701A1 (en) | 2019-05-14 | 2022-08-11 | The Broad Institute, Inc. | Compositions and methods for targeting multinucleated cells |
| US20220235340A1 (en) | 2019-05-20 | 2022-07-28 | The Broad Institute, Inc. | Novel crispr-cas systems and uses thereof |
| US20220220469A1 (en) | 2019-05-20 | 2022-07-14 | The Broad Institute, Inc. | Non-class i multi-component nucleic acid targeting systems |
| US20220243178A1 (en) | 2019-05-31 | 2022-08-04 | The Broad Institute, Inc. | Methods for treating metabolic disorders by targeting adcy5 |
| CA3140668A1 (en) | 2019-06-12 | 2020-12-17 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
| EP3983537A1 (en) | 2019-06-12 | 2022-04-20 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
| CN114555625B (zh) * | 2019-07-02 | 2025-02-25 | 塔夫茨学院托管部 | 用于将剂递送至细胞和组织中的新型肽、组合物和方法 |
| US20230092895A1 (en) | 2019-08-30 | 2023-03-23 | Obsidian Therapeutics, Inc. | Tandem cd19 car-based compositions and methods for immunotherapy |
| US20220298501A1 (en) | 2019-08-30 | 2022-09-22 | The Broad Institute, Inc. | Crispr-associated mu transposase systems |
| WO2021046451A1 (en) | 2019-09-06 | 2021-03-11 | Obsidian Therapeutics, Inc. | Compositions and methods for dhfr tunable protein regulation |
| US12297426B2 (en) | 2019-10-01 | 2025-05-13 | The Broad Institute, Inc. | DNA damage response signature guided rational design of CRISPR-based systems and therapies |
| US11981922B2 (en) | 2019-10-03 | 2024-05-14 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment |
| CA3163838A1 (en) | 2020-01-08 | 2021-07-15 | Vipin Suri | Compositions and methods for tunable regulation of transcription |
| WO2021146641A1 (en) | 2020-01-17 | 2021-07-22 | The Broad Institute, Inc. | Small type ii-d cas proteins and methods of use thereof |
| CN111840334A (zh) * | 2020-07-21 | 2020-10-30 | 温州医科大学附属第一医院 | 普雷沃氏菌属在治疗或预防骨质疏松中的应用 |
| AU2021321586A1 (en) | 2020-08-07 | 2023-03-16 | Dana-Farber Cancer Institute, Inc. | Therapeutic targeting of phosphate dysregulation in cancer via the XPR1:KIDINS220 protein complex |
| WO2022044167A1 (ja) * | 2020-08-26 | 2022-03-03 | オリンパス株式会社 | 幹細胞の分化を評価するシステム、方法、及び、プログラム |
| CA3195442A1 (en) * | 2020-10-18 | 2022-04-21 | Jean-Pascal LEPETIT-STOFFAES | Peptide-based transduction of non-anionic polynucleotide analogs for gene expression modulation |
| KR20230088828A (ko) * | 2020-10-22 | 2023-06-20 | 펠단 바이오 인코포레이티드 | Cas9-rnp 및 기타 핵단백질 카고의 형질도입을 위해 적합화된 최소 길이의 셔틀제 펩타이드 및 그의 변이체 |
| KR102803305B1 (ko) * | 2020-11-25 | 2025-05-07 | 연세대학교 산학협력단 | 트랜스-스플라이싱 아데노-연관 바이러스 벡터를 포함하는 프라임에디팅용 조성물 |
| CN115998894B (zh) * | 2021-10-21 | 2025-05-27 | 福州大学 | 一种硫属元素杂环化合物和胰岛素组装形成的团聚体及其制备方法和胰岛素口服制剂 |
| GB202116307D0 (en) | 2021-11-12 | 2021-12-29 | Syngenta Crop Protection Ag | Herbicide resistance |
| WO2023093862A1 (en) | 2021-11-26 | 2023-06-01 | Epigenic Therapeutics Inc. | Method of modulating pcsk9 and uses thereof |
| CN115724990A (zh) * | 2022-07-19 | 2023-03-03 | 杭州纽龙生物科技有限公司 | 一种不影响与肝素结合能力的融合fgf1蛋白序列及对应的dna序列 |
| UY40630A (es) | 2023-02-03 | 2024-08-15 | Syngenta Crop Protection Ag | “Plantas y partes de estas que se han modificado para comprender una enzima BioA o BIO3-BIO1 (BioDA |
| UY40714A (es) | 2023-04-19 | 2024-12-13 | Syngenta Crop Protection Ag | Una enzima o fragmento funcional de protoporfirinógeno oxidasa (ppo) modificado, y plantas que compr |
| CN116578092B (zh) * | 2023-05-29 | 2023-11-14 | 汕头大学 | 一种基于基因调控网络的智能体集群运动控制方法及系统 |
| WO2025019713A2 (en) | 2023-07-18 | 2025-01-23 | Beth Israel Deaconess Medical Center, Inc. | Protein-based delivery system |
| WO2025059533A1 (en) | 2023-09-13 | 2025-03-20 | The Broad Institute, Inc. | Crispr enzymes and systems |
| WO2025096916A1 (en) | 2023-11-03 | 2025-05-08 | The Broad Institute, Inc. | Multi-site editing in living cells |
| WO2025117544A1 (en) | 2023-11-29 | 2025-06-05 | The Broad Institute, Inc. | Engineered omega guide molecule and iscb compositions, systems, and methods of use thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015038662A1 (en) * | 2013-09-10 | 2015-03-19 | The Texas A&M University System | Compositions and methods for the delivery of molecules into live cells |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030104622A1 (en) | 1999-09-01 | 2003-06-05 | Robbins Paul D. | Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses |
| FR2849603B1 (fr) | 2003-01-07 | 2006-09-08 | Centre Nat Rech Scient | Composition pour le transport intracellulaire de macromolecules ou particules biologiques |
| CN1958606A (zh) * | 2005-10-31 | 2007-05-09 | 中国人民解放军军事医学科学院基础医学研究所 | 一种重组肝癌复合表位抗原,其制备方法及在制备肝癌特异免疫治疗药物中的应用 |
| US7579318B2 (en) | 2005-12-06 | 2009-08-25 | Centre De La Recherche De La Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| WO2007069090A2 (en) | 2005-12-06 | 2007-06-21 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| CA2658180A1 (en) * | 2006-07-19 | 2008-01-31 | University Of Florida Research Foundation, Inc. | Compositions for reprogramming a cell and uses therefor |
| US9737604B2 (en) | 2013-09-06 | 2017-08-22 | President And Fellows Of Harvard College | Use of cationic lipids to deliver CAS9 |
| WO2015089462A1 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for genome editing |
| JP6956705B2 (ja) | 2015-04-10 | 2021-11-02 | フェルダン・バイオ・インコーポレーテッド | 標的真核細胞のサイトゾルへのポリペプチドカーゴの形質導入効率を改善するためのポリペプチドベースのシャトル剤、その使用、それと関連する方法及びキット |
| CA2996982A1 (en) | 2015-09-23 | 2017-03-30 | Universite Laval | Modification of the dystrophin gene and uses thereof |
| WO2017175072A1 (en) | 2016-04-08 | 2017-10-12 | Feldan Bio Inc. | Peptide shuttle based gene disruption |
| WO2018053632A1 (en) | 2016-09-23 | 2018-03-29 | UNIVERSITé LAVAL | Methods of modifying the dystrophin gene and restoring dystrophin expression and uses thereof |
| US9982267B2 (en) | 2016-10-12 | 2018-05-29 | Feldan Bio Inc. | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same |
| AU2017341736B2 (en) | 2016-10-12 | 2022-09-08 | Feldan Bio Inc. | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same |
| US11629170B2 (en) * | 2016-10-12 | 2023-04-18 | Feldan Bio Inc. | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same |
| CA3040645A1 (en) | 2019-04-18 | 2020-10-18 | Feldan Bio Inc. | Peptide-based non-proteinaceous cargo delivery |
-
2016
- 2016-04-08 JP JP2018503698A patent/JP6956705B2/ja active Active
- 2016-04-08 US US15/094,365 patent/US9738687B2/en active Active
- 2016-04-08 KR KR1020217032040A patent/KR102697262B1/ko active Active
- 2016-04-08 CN CN201680033851.3A patent/CN107636017B/zh active Active
- 2016-04-08 CA CA2981716A patent/CA2981716C/en active Active
- 2016-04-08 CA CA3149413A patent/CA3149413C/en active Active
- 2016-04-08 ES ES16775984T patent/ES2864758T3/es active Active
- 2016-04-08 SG SG11201708336YA patent/SG11201708336YA/en unknown
- 2016-04-08 KR KR1020177032555A patent/KR20170135957A/ko not_active Ceased
- 2016-04-08 AU AU2016245347A patent/AU2016245347B2/en active Active
- 2016-04-08 WO PCT/CA2016/050403 patent/WO2016161516A1/en not_active Ceased
- 2016-04-08 EP EP16775984.4A patent/EP3280739B1/en active Active
-
2017
- 2017-04-12 US US15/486,155 patent/US10633421B2/en active Active
- 2017-10-08 IL IL254919A patent/IL254919B/en unknown
-
2020
- 2020-02-21 US US16/797,867 patent/US12060387B2/en active Active
-
2021
- 2021-06-01 JP JP2021092230A patent/JP2021121224A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015038662A1 (en) * | 2013-09-10 | 2015-03-19 | The Texas A&M University System | Compositions and methods for the delivery of molecules into live cells |
Non-Patent Citations (3)
| Title |
|---|
| JI-SING LIOU ET AL, "Protein transduction in human cells is enhanced by cell penetrating peptides fused with an endosomolytic HA2 sequence", PEPTIDES, AMSTERDAM, NL, (2012-10-01), vol. 37, no. 2, pages 273 - 284 * |
| SALOMONE F et al., "A novel chimeric cell -penetrating peptide with membrane-disruptive properties for efficient endosomal escape''.", Journal of Controlled Release., (2012-11-10), vol. 163, no. 3, ISSN 0168-3659, pages 293 - 303 * |
| YA-JUNG LEE ET AL, "Delivery of Macromolecules into Live Cells by Simple Co-incubation with a Peptide", CHEMBIOCHEM - A EUROPEAN JOURNAL OF CHEMICAL BIOLOGY., DE, (2010-02-15), vol. 11, no. 3, pages 325 - 330 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016245347A1 (en) | 2017-11-09 |
| CA2981716A1 (en) | 2016-10-13 |
| US20170267728A1 (en) | 2017-09-21 |
| SG11201708336YA (en) | 2017-11-29 |
| US9738687B2 (en) | 2017-08-22 |
| CA3149413C (en) | 2025-07-08 |
| KR20170135957A (ko) | 2017-12-08 |
| CN107636017B (zh) | 2022-05-31 |
| JP2018512891A (ja) | 2018-05-24 |
| WO2016161516A1 (en) | 2016-10-13 |
| IL254919B (en) | 2022-04-01 |
| EP3280739B1 (en) | 2020-12-30 |
| CA2981716C (en) | 2022-04-12 |
| US20200181202A1 (en) | 2020-06-11 |
| US20160298078A1 (en) | 2016-10-13 |
| ES2864758T3 (es) | 2021-10-14 |
| EP3280739A1 (en) | 2018-02-14 |
| US12060387B2 (en) | 2024-08-13 |
| JP6956705B2 (ja) | 2021-11-02 |
| KR102697262B1 (ko) | 2024-08-20 |
| CA3149413A1 (en) | 2016-10-13 |
| IL254919A0 (en) | 2017-12-31 |
| CN107636017A (zh) | 2018-01-26 |
| KR20210124536A (ko) | 2021-10-14 |
| EP3280739A4 (en) | 2018-12-26 |
| US10633421B2 (en) | 2020-04-28 |
| JP2021121224A (ja) | 2021-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016245347B2 (en) | Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same | |
| US12286632B2 (en) | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same | |
| US9982267B2 (en) | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same | |
| US11629170B2 (en) | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same | |
| WO2017175072A1 (en) | Peptide shuttle based gene disruption | |
| US12428447B2 (en) | Peptide-based non-proteinaceous cargo delivery |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |